Inactive Instrument

Highlights Lpath, Inc. Nasdaq

Equities

US5489103060

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2023	Apollo Endosurgery, Inc.(NasdaqGM:APEN) dropped from S&P TMI Index	CI
2023	Apollo Endosurgery, Inc.(NasdaqGM:APEN) dropped from S&P Global BMI Index	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Boston Scientific Corporation completed the acquisition of Apollo Endosurgery, Inc. from a group of shareholders.	23-04-03	CI
North American Morning Briefing : Futures Dip As a -2-	23-01-05	DJ
Apollo Endosurgery : Merger Agreement - Form 8-K	22-12-28	PU
Apollo Endosurgery Shares Hit 52-Week High on Boston Scientific Deal	22-11-29	DJ
Boston Scientific Strikes $615 Million Deal to Buy Medical Tech Firm Apollo Endosurgery	22-11-29	MT
Boston Scientific to Acquire Apollo Endosurgery for $615 Million; Apollo Shares Jump	22-11-29	MT
Boston Scientific to buy Apollo Endosurgery for $417 million	22-11-29	RE
Boston Scientific to Buy Apollo Endosurgery	22-11-29	DJ
Boston Scientific to acquire Apollo Endosurgery in $615 mln deal	22-11-29	RE
Boston Scientific Corporation entered into a definitive merger agreement to acquire Apollo Endosurgery, Inc. from a group of shareholders for approximately $500 million.	22-11-28	CI
Apollo Endosurgery, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-01	CI
Apollo Endosurgery, Inc. Raises Revenue Guidance for the Fiscal Year 2022	22-11-01	CI
Apollo Endosurgery, Inc. Enters into Third Amendment to the Lease	22-10-06	CI
Apollo Endosurgery, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-02	CI
Apollo Endosurgery Says FDA Awards De Novo Marketing Authorization for 4 Weight-Loss Devices; Shares Rise Pre-Bell	22-07-13	MT
FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG(TM) and Apollo REVISE(TM), New Endoscopic Systems for Patients with Obesity	22-07-13	CI
Apollo Endosurgery, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-03	CI
Apollo Endosurgery, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-22	CI
Apollo Endosurgery, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-02-22	CI
Earnings Flash (APEN) APOLLO ENDOSURGERY Posts Q4 Revenue $16.2M, vs. Street Est of $16.2M	22-02-22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Lpath, Inc. Nasdaq

Equities

US5489103060

Highlights

Filters